Triple
T11553578
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Patrick Soon-Shiong |
E273954
|
entity |
| Predicate | founded |
P104
|
FINISHED |
| Object |
NantKwest
NantKwest is a biotechnology company focused on developing natural killer (NK) cell-based immunotherapies for cancer and other diseases.
|
E932805
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d6aae4dfa48190a3ab0b19a159a3c5 |
elicitation | completed |
| NER | batch_69d88a85b9ac8190a57c1fdaeacbe3d6 |
ner | completed |
| NED1 | batch_69e6e851a6688190996580a077496833 |
ned_source_triple | completed |
| NED2 | batch_69e6f9144afc819081ee7f78e32ad39a |
ned_description | completed |
| NEDg | batch_69e6ef93e7d88190af3853b82de23c1b |
nedg | completed |
Created at: April 8, 2026, 9:37 p.m.